EUCTR2008-000051-10-GB进行中（未招募）不适用
11C metomidate PET scanning for Conn's syndrome
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge0 个研究点开始时间: 2008年5月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female
- •Age >=18yrs
- •Suspected Conn's syndrome (hypertension BP>140/90mmHg, plasma aldosterone >400pmol/L, raised aldosterone:renin ratio, hypokalaemia, Na+ >140mmol/L, metabolic alkalosis, likely adenoma on CT/MR imaging of adrenal glands)
- •Suspected bilateral adrenal hyperplasia (evidence of hyperaldosteronism, bilateral adrenal enlargement on CT/MR imaging of adrenal glands and failure of lateralisation of aldosterone secretion on adrenal venous sampling)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Inability to give informed consent
- •Heart failure (risk of worsening of condition with fludrocortisone administration)
研究者
相似试验
招募中
不适用
11C-acetate PET for Multiple sclerosisMultiple Sclerosis, NMOJPRN-UMIN000018154department of neurology, Osaka university school of medicine30
尚未招募
不适用
C-11-Methionine-PET/CT evaluation of the occurrence of local recurrence and metastasis, and assessment of the prognosis regarding brain tumor, orbital tumor and head and neck region cancer treated by carbon ion radiotherapyBrain tumor, orbital tumor, head and neck region cancerJPRN-UMIN000009017ational Institute of Radiological Sciences350
尚未招募
不适用
C-11-Methionine-PET/CT evaluation of the occurrence of local recurrence and metastasis, and assessment of the prognosis regarding tumor in region from lower abdomen to pelvis treated by carbon ion radiotherapytumor in region from lower abdomen to pelvisJPRN-UMIN000009018ational Institute of Radiological Sciences300
进行中（未招募）
不适用
PET/CT-biopsi studyA PET/CT biopsy study in patients Capecitabine +/- Sorafenib in the treatment of locally advanced or metastatic HER2-negative breast cancer.Morphological verifications of metastatic lesions, PET Ribonucleic Acid (RNA)-expression study in subjects with locally advance or metastatic HER2-negative breast cancer.MedDRA version: 14.1Level: LLTClassification code 10004244Term: Benign breast neoplasm NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-002053-29-SEKarolinska Institutet and University Hospital
已完成
不适用
[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseasesJPRN-UMIN000023101Tokyo Medical and Dental University40